Arotinolol is a pharmaceutical raw material that functions as a mixed alpha/beta adrenoceptor blocking agent and also exhibits beta-3 receptor agonist activity. It was first described in the scientific literature in 1979 as a beta-adrenergic blocking and antiarrhythmic compound.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 41287-43-8
Alfacalcidol
active pharmaceutical ingredient
Etodolac
Non-steroidal anti-inflammatory active ingredient
4,10-anhydro(N-((6R)-6-methyloctanoyl)-L-2,4-diaminobutanoyl-L-threonyl-L-2,4-diaminobutanoyl-L-2,4-diaminobutanoyl-L-2,4-diaminobutanoyl-D-phenylalanyl-L-leucyl-L-2,4-diaminobutanoyl-L-2,4-diaminobutanoyl-L-threonine)
polymyxin antibiotic active pharmaceutical ingredient
Cyproheptadine hydrochloride sesquihydrate
active pharmaceutical ingredient
7-chloro-4-[5-(2-sulfosulfanylethylamino)pentoxy]quinoline
CKQHXOCXLJZGSX-UHFFFAOYSA-N
C1=CC2=C(C=CN=C2C=C1Cl)OCCCCCNCCSS(=O)(=O)O